This inventor holds 1 USPTO granted patent. Top assignee: Nymox Corporation. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Celine Dupuis: Innovator in Amyloidosis Detection
Introduction
Celine Dupuis is a notable inventor based in Beaconsfield, Canada. She has made significant contributions to the field of medical diagnostics, particularly in the detection of amyloidosis. Her innovative approach has the potential to improve the diagnosis and treatment monitoring of this complex condition.
Latest Patents
Celine Dupuis holds a patent for a method of detecting amyloid-containing lesions by autofluorescence. This method allows for the detection of amyloid-containing deposits in mammals without the need for exogenous chemicals such as fluorophores or chromophores. The technique involves subjecting tissue suspected of amyloidosis to specific excitation radiation, producing emitted and reflected light signals that can be analyzed for diagnostic purposes. This non-invasive imaging method can be instrumental in diagnosing amyloidosis in living mammals and monitoring treatment efficacy.
Career Highlights
Celine Dupuis is associated with Nymox Corporation, where she applies her expertise in medical diagnostics. Her work focuses on developing innovative solutions that enhance the understanding and treatment of amyloidosis. With her patent, she has positioned herself as a key figure in advancing diagnostic methodologies in the medical field.
Collaborations
Celine collaborates with Paul A Averback, contributing to the research and development efforts at Nymox Corporation. Their combined expertise fosters innovation and drives progress in the detection of amyloid-related conditions.
Conclusion
Celine Dupuis is a pioneering inventor whose work in amyloidosis detection exemplifies the intersection of innovation and healthcare. Her patented method represents a significant advancement in non-invasive diagnostic techniques, promising to enhance patient care and treatment outcomes.